Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 122841 | Eniporide | 176644-21-6 | 98% |  |
| Coming soon! | ||||
| 122811 | Enasidenib | 1446502-11-9 | 98% |  |
| Enasidenib is a oral potent, selective, reversible inhibitor of mutant IDH2. | ||||
| 121413 | Elagolix | 834153-87-6 | 98% |  |
| Elagolix is a Gonadotropin-Releasing Hormone (GnRH) Antagonist. | ||||
| 5121008 | ethyl 5-chloro-7-nitro-1H-indole-2-carboxylate | 91119-27-6 | 98% by HPLC |  |
| ethyl 5-chloro-7-nitro-1H-indole-2-carboxylate,CAS#91119-27-6 | ||||
| 120411 | Enoxacin | 74011-58-8 | 98% |  |
| Coming soon! | ||||
| 120112 | EPZ011989 | 1598383-40-4 | 98% |  |
| EPZ011989 is a potent, selective orally bioavailable EZH2 inhibitor with Ki < 3 nM | ||||
| 5112801 | Elafibranor (GFT505) | 923978-27-2 | ≧98.0% | _923978-27-2.png) |
| Elafibranor, also known as GFT-505, is a dual PPARα/δ agonist. Elafibranoris curren | ||||
| 111909 | ENMD-2076 | 934353-76-1 | 98% |  |
| ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.8 | ||||
| 111004 | Eliprodil | 119431-25-3 | 98% |  |
| Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent | ||||
| 110209 | Ethyl 4,6-dichloropyridazine-3-carboxylate | 679406-03-2 | 98% |  |
| Coming soon! | ||||
| 102615 | EHop-016 | 1380432-32-5 | 98% |  |
| EHop-016 is a novel potent and selective inhibitor of Rac GTPase; inhibits Rac1 activ | ||||
| 102608 | 4EGI-1 | 315706-13-9 | 98% |  |
| 4EGI-1 is a cell-permeable hydrazone compound that reversibly binds eukaryotic transl | ||||
| 102602 | EHT 1864 | 754240-09-0 | 98% |  |
| EHT 1864 is a small molecule inhibitor of Rac1 signaling; modulate _gamma_-Secretase- | ||||
| 101920 | Epirubicin hydrochloride | 56390-09-1 | 98% |  |
| Coming soon! | ||||
| 100504 | Entrectinib(RXDX-101) | 1108743-60-7 | 98% by HPLC | -cas-1108743-60-7.png) |
| Entrectinib (RXDX-101) is a selective inhibitor for all three TRK receptor tyrosine k | ||||
| 92209 | ethyl 1-amino-2-ethenylcyclopropane-1-carboxylate | 787548-29-2 | 98% |  |
| Coming soon! | ||||
| 91807 | Ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate | 1257213-52-7 | 98% | phenyl)cyclopropanecarboxylate-cas-1257213-52-7.png) |
| Coming soon! | ||||
| 91707 | Ethyl 3-(4-fluorophenyl)-1H-pyrazole-5-carboxylate | 866588-11-6 | 98% | -1H-pyrazole-5-carboxylate-cas-866588-11-6.png) |
| Coming soon! | ||||
| 91413 | ethyl 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylate | 68301-99-5 | 98% |  |
| The related API: AmoxanoxThe related intermediates: 4-oxo-6-propan-2-ylchromene-3-car | ||||
| 90104 | Ethyl L-pyroglutamate | 7149-65-7 | 98% |  |
| Coming soon! | ||||
| 82729 | (E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid | 1516887-33-4 | 98% | -3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oicacid-cas-1516887-33-4.png) |
| Coming soon! | ||||
| 82710 | 3-(4-ethoxycarbonyl-5-methyl-1H-pyrrol-3-yl)propanoic acid | 38664-16-3 | 98% | propanoicacid-cas-38664-16-3.png) |
| Coming soon! | ||||
| 82709 | Etoricoxib | 202409-33-4 | 98% |  |
| Etoricoxib selectively inhibited COX-2 in human whole blood assays in vitro, with an | ||||
| 82603 | Ertugliflozin | 1210344-57-2 | 98% |  |
| Ertugliflozin is a potent and selective inhibitor of the sodium-dependent glucose cot | ||||
| 81312 | Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate | 172336-32-2 | 98% | -35-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate-cas-172336-32-2.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81311 | Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate | 148901-69-3 | 98% | -7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate-cas-148901-69-3.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81310 | (E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal | 148901-68-2 | 98% | -3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal-cas-148901-68-2.png) |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81302 | Ethyl 3-cyclopropyl-3-oxopropanoate | 24922-02-9 | 98% |  |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 32249-35-7 M | ||||
| 81010 | Ethyl 3-bromo-4-ethylbenzoate | 1131615-08-1 | 97% |  |
| Coming soon! | ||||
| 81002 | Endoxifen | 112093-28-4 | 97% |  |
| Endoxifen is a novel active metabolite of the anti-cancer drug, Tamoxifen, and it con | ||||